# Clinical Determinants of Disease Progression in Patients With Limb Girdle Muscular Distrophy Type 2E

> **NCT04509609** · — · COMPLETED · sponsor: **Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico** · enrollment: 33 (actual)

## Conditions studied

- LGMD2E

## Interventions

- **OTHER:** Exon 3 truncating mutation
- **OTHER:** Any other mutation in SGBC gene

## Key facts

- **NCT ID:** NCT04509609
- **Lead sponsor:** Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-06-01
- **Primary completion:** 2020-09-30
- **Final completion:** 2021-09-30
- **Target enrollment:** 33 (ACTUAL)
- **Last updated:** 2022-03-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04509609

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04509609, "Clinical Determinants of Disease Progression in Patients With Limb Girdle Muscular Distrophy Type 2E". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04509609. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*